AbbVie Inc. 5.5% 15-MAR-2064AbbVie Inc. 5.5% 15-MAR-2064AbbVie Inc. 5.5% 15-MAR-2064

AbbVie Inc. 5.5% 15-MAR-2064

No trades
See on Supercharts

ABBV5759196 analysis



Key facts


Issue date
Feb 26, 2024
Maturity date
Mar 15, 2064
Outstanding amount
‪1.50 B‬USD
Face value
1,000.00USD
Minimum denomination
2,000.00USD
Coupon
5.50% (Fixed)
Yield to maturity
5.39%
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.